Tumor News and Research

RSS

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Researchers from Lombardi Comprehensive Cancer Center at Georgetown University found that testing for an activated Stat5 protein in prostate tumor tissue effectively predicts which men have a form of prostate cancer that may become more aggressive and life threatening.

15 Aug 2005

Researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer

The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.

13 Aug 2005

Plasma exchange treatment shown most helpful for severe attacks in subtype of MS patients

A Mayo Clinic study demonstrates that only those multiple sclerosis (MS) patients with evidence for antibody deposition or complement activation -- immune cells that can cause tissue destruction -- in their lesions are likely to respond to plasma exchange, a treatment for acute MS attacks.

11 Aug 2005

Protein that protects the body from tissue damage also increases the risk of tumors

You win some, you lose some. A protein that protects the body from tissue damage also increases the risk of tumors, according to a study conducted at Washington University School of Medicine in St. Louis. Moderate reduction of the protein level protects against tumor formation but increases susceptibility to tissue injury.

11 Aug 2005

Defect in the gene that makes YAP might contribute to cancer

Johns Hopkins scientists have identified a protein in fruit flies whose counterpart product in humans may help cause cancer.

11 Aug 2005

Introgen announces additional broad patent in China

Introgen Therapeutics has announced that a patent with broad claims directed to combination therapy with the p53 gene and conventional chemotherapy or radiation was issued in China.

11 Aug 2005

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

Researchers have discovered that tumors release fatty acids that interfere with the cells that are trying to kill them. Consequently, strategies that reduce the amount of fatty acids surrounding the tumors may give a boost to anti-cancer therapeutics.

11 Aug 2005

Lifestyle changes may affect the progression of any type of cancer

Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

Open nephron-sparing surgery remains the most desirable for the patients

Urologists often view less-invasive surgery techniques as more desirable for the patient, but in a study of open nephron-sparing surgeries (NSS) from 1985 to 2001 at Mayo Clinic, researchers found that the "gold standard" of open surgery for kidney tumors should remain the first choice for many patients. The study appears online today in The Journal of Urology.

10 Aug 2005

Firefly protein lets researchers monitor molecule known as IKK (for IKappa kinase) linked to cancer

Scientists have used a glowing protein from fireflies to observe the activity of a molecule that is an important target for new drugs to treat cancer, autoimmune diseases and several other disorders.

9 Aug 2005

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes.

9 Aug 2005

Non-melanoma skin cancers in young adults has increased significantly in the last three decades

"Because non-melanoma skin cancers generally occur in persons after 50, very little attention has been paid to their incidence in younger adults and children," says Leslie Christenson, M.D., Mayo Clinic dermatologist and lead investigator of the study.

9 Aug 2005

Scientists enhance the anti-cancer properties of a digitalis, a drug commonly used to treat heart disease

Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.

9 Aug 2005

Study results reaffirm cyclin D1 as a candidate target for molecular therapeutic control of breast tumor development

For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal state, helps keep tumor formation in check. About five to 10 percent of breast cancer cases arise from these genetic miscues, about half of which are linked to the abnormal functioning of BRCA1.

9 Aug 2005

Scientists identify protein that may inhibit cellular movement

Scientists from the University of North Carolina at Chapel Hill School of Medicine and the UNC Lineberger Comprehensive Cancer Center have identified a protein that may inhibit cellular movement, or migration.

8 Aug 2005

Failure to account for shift in tumor size can lead to overestimation of the impact of treatment advances

A new study finds that the size of newly diagnosed breast cancers has shifted towards smaller tumors, even within conventional cancer stage categories, and that this shift accounts for a proportion of the improvement seen in breast cancer survival over the last 30 years.

8 Aug 2005

Protein p53 is the "guardian" of our genome

When DNA damage is present, p53 stops cell division and gives the cell enough time to repair it. If the damage is irreparable, the protein sets off programmed cell death and protects the cells from degeneration.

7 Aug 2005

Scientist have found an unexpected effect of the interaction of PTEN and p53 genes in early stage prostate cancer

Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.

3 Aug 2005

Customized gene chip offers clues to prognosis in cases of neuroblastoma

Rather than covering the entire genome, the microarray focuses on suspect regions of chromosomes for signs of deleted genetic material known to play a role in the cancer.

2 Aug 2005

Tumor News and Research

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Researchers have found a signal that could lead to earlier detection and treatment of ovarian cancer

Plasma exchange treatment shown most helpful for severe attacks in subtype of MS patients

Protein that protects the body from tissue damage also increases the risk of tumors

Defect in the gene that makes YAP might contribute to cancer

Introgen announces additional broad patent in China

Researchers discover that tumors secrete fatty acids which inhibit the cytotoxic T lymphocytes' ability to kill tumor cells

Lifestyle changes may affect the progression of any type of cancer

FDA approval sought for Pfizer's new cancer drug

Open nephron-sparing surgery remains the most desirable for the patients

Firefly protein lets researchers monitor molecule known as IKK (for IKappa kinase) linked to cancer

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Non-melanoma skin cancers in young adults has increased significantly in the last three decades

Scientists enhance the anti-cancer properties of a digitalis, a drug commonly used to treat heart disease

Study results reaffirm cyclin D1 as a candidate target for molecular therapeutic control of breast tumor development

Scientists identify protein that may inhibit cellular movement

Failure to account for shift in tumor size can lead to overestimation of the impact of treatment advances

Protein p53 is the "guardian" of our genome

Scientist have found an unexpected effect of the interaction of PTEN and p53 genes in early stage prostate cancer

Customized gene chip offers clues to prognosis in cases of neuroblastoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News